Healthium, a global player in medical devices, has acquired AbGel gelatin sponge business from Mumbai-based Shri SGK Labs, adding to its product portfolio focused on surgical and post-surgical care.

Earlier this financial year, the company had acquired VitalCare Group in the UK to grow its urology portfolio and expand its market in Europe and the US.

Bengaluru-based Healthium aims to further expand the market access of this portfolio using its wide network of hospitals across India.

AbGel is an absorbable gelatin sponge, manufactured from highly purified neutral gelatin with haemostatic capabilities and is designed to control blood oozing in instances of haemorrhage from multiple small vessels, and is completely absorbed in four to five weeks with no residue or encapsulation. It is non-toxic, non-allergic, non-immunogenic and non-pyrogenic. 

AbGel is beneficial in effectively managing this across a wide variety of specialities including abdominal surgery, neurosurgery, gynaecological surgery, ENT surgery, dental surgery and oncosurgery. 

Speaking on the acquisition, Anish Bafna, CEO and MD, Healthium Medtech, said, “Hemostasis during surgical procedures is an area of concern for surgeons. We are excited to add a brand like AbGel that is a recognised brand in the gelatin sponge category and has been contributing to safer surgeries for over four decades. This acquisition strengthens our presence in the category and our commitment to drive value for our customers.”